Ascendis Pharma A (ASND) Interest & Investment Income (2012 - 2026)

Ascendis Pharma A has disclosed Interest & Investment Income across 15 years of filings, most recently posting $5.3 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $5.3 million, down 82.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 million (down 82.58% YoY), and the FY2025 annual result was $132.7 million, up 384.91% from the prior year.
• Interest & Investment Income came in at $5.3 million for Q1 2026 at Ascendis Pharma A, down from $105.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $105.2 million in Q3 2025 to a low of $3.9 million in Q1 2024.
• The 5-year median for Interest & Investment Income is $63.6 million (2024), against an average of $57.6 million.
• Across the five-year window, Interest & Investment Income slumped 91.98% in 2024 and surged 681.49% in 2025, its largest moves.
• Ascendis Pharma A's Interest & Investment Income stood at $74.4 million in 2022, then grew by 12.24% to $83.5 million in 2023, then slumped by 61.52% to $32.1 million in 2024, then surged by 227.22% to $105.2 million in 2025, then sank by 94.97% to $5.3 million in 2026.
• The last three Interest & Investment Income figures came in at $5.3 million (Q1 2026), $105.2 million (Q3 2025), and $95.0 million (Q2 2025), per Business Quant data.